STAT3‐dependent analysis revealsPDK4as independent predictor of recurrence in prostate cancer

Male Proteomics 104002 Analytische Chemie Medicine (General) Oxidative Phosphorylation STAT3 Mice 106023 Molekularbiologie Biology (General) 0303 health sciences GENE ONTOLOGY Applied Mathematics Systems Biology Articles 106023 Molecular biology prostate cancer Prognosis OXPHOS 3. Good health ACID CYCLE GENOME Gene Expression Regulation, Neoplastic PDK4 Computational Theory and Mathematics SDG 3 – Gesundheit und Wohlergehen General Agricultural and Biological Sciences 301904 Cancer research Information Systems STAT3 Transcription Factor COMPUTATIONAL PLATFORM DNA ELEMENTS QH301-705.5 301904 Krebsforschung Laser Capture Microdissection METABOLISM General Biochemistry, Genetics and Molecular Biology Young Adult 03 medical and health sciences R5-920 104002 Analytical chemistry SDG 3 - Good Health and Well-being TARGET GENES Biomarkers, Tumor Animals Humans TCA cycle General Immunology and Microbiology Gene Expression Profiling Prostatic Neoplasms Pyruvate Dehydrogenase Acetyl-Transferring Kinase Neoplasms, Experimental ENCYCLOPEDIA DIFFERENTIAL EXPRESSION ANALYSIS Neoplasm Grading Neoplasm Recurrence, Local
DOI: 10.15252/msb.20199247 Publication Date: 2020-04-23T10:00:37Z
ABSTRACT
Prostate cancer (PCa) has a broad spectrum of clinical behavior; hence, biomarkers are urgently needed for risk stratification. Here, we aim to find potential stratification, by utilizing gene co-expression network transcriptomics data in addition laser-microdissected proteomics from human and murine prostate FFPE samples. We show up-regulation oxidative phosphorylation (OXPHOS) PCa on the transcriptomic level TCA cycle/OXPHOS proteomic level, which is inversely correlated STAT3 expression. hereby identify expression pyruvate dehydrogenase kinase 4 (PDK4), key regulator cycle, as promising independent prognostic marker PCa. PDK4 predicts disease recurrence diagnostic factors such grading, staging, PSA level. Therefore, low with dismal prognosis.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (127)
CITATIONS (49)